Global Eliglustat API Market Research Report 2024

Publication ID:

PB502241277

Publication Date:

February 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease in patients who are CYP2D6 extensive metabolizers, intermediate metabolizers , or poor metabolizers in treatment-naive and treatment-experi.
The global Eliglustat API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eliglustat API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eliglustat API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eliglustat API include Tecoland, Liverpool Biopharma, Clearsynth, Pharmaffiliates, AR Life Sciences, Symphony Pharma Life Sciences, Zhejiang Ausun Pharmaceutical, CoreSyn and Cangzhou Enke Pharma Tech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eliglustat API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eliglustat API.
Report Scope
The Eliglustat API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eliglustat API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eliglustat API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tecoland
Liverpool Biopharma
Clearsynth
Pharmaffiliates
AR Life Sciences
Symphony Pharma Life Sciences
Zhejiang Ausun Pharmaceutical
CoreSyn
Cangzhou Enke Pharma Tech
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Pharmaceutical
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eliglustat API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Eliglustat API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Eliglustat API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Eliglustat API Market Overview
1.1 Product Definition
1.2 Eliglustat API Segment by Type
1.2.1 Global Eliglustat API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Eliglustat API Segment by Application
1.3.1 Global Eliglustat API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Research
1.3.3 Pharmaceutical
1.4 Global Market Growth Prospects
1.4.1 Global Eliglustat API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Eliglustat API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Eliglustat API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Eliglustat API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Eliglustat API Production Market Share by Manufacturers (2019-2024)
2.2 Global Eliglustat API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Eliglustat API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Eliglustat API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Eliglustat API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Eliglustat API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Eliglustat API, Product Offered and Application
2.8 Global Key Manufacturers of Eliglustat API, Date of Enter into This Industry
2.9 Eliglustat API Market Competitive Situation and Trends
2.9.1 Eliglustat API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Eliglustat API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Eliglustat API Production by Region
3.1 Global Eliglustat API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Eliglustat API Production Value by Region (2019-2030)
3.2.1 Global Eliglustat API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Eliglustat API by Region (2025-2030)
3.3 Global Eliglustat API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Eliglustat API Production by Region (2019-2030)
3.4.1 Global Eliglustat API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Eliglustat API by Region (2025-2030)
3.5 Global Eliglustat API Market Price Analysis by Region (2019-2024)
3.6 Global Eliglustat API Production and Value, Year-over-Year Growth
3.6.1 North America Eliglustat API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Eliglustat API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Eliglustat API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Eliglustat API Production Value Estimates and Forecasts (2019-2030)
3.6.5 India Eliglustat API Production Value Estimates and Forecasts (2019-2030)
4 Eliglustat API Consumption by Region
4.1 Global Eliglustat API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Eliglustat API Consumption by Region (2019-2030)
4.2.1 Global Eliglustat API Consumption by Region (2019-2024)
4.2.2 Global Eliglustat API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Eliglustat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Eliglustat API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Eliglustat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Eliglustat API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Eliglustat API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Eliglustat API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Eliglustat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Eliglustat API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Eliglustat API Production by Type (2019-2030)
5.1.1 Global Eliglustat API Production by Type (2019-2024)
5.1.2 Global Eliglustat API Production by Type (2025-2030)
5.1.3 Global Eliglustat API Production Market Share by Type (2019-2030)
5.2 Global Eliglustat API Production Value by Type (2019-2030)
5.2.1 Global Eliglustat API Production Value by Type (2019-2024)
5.2.2 Global Eliglustat API Production Value by Type (2025-2030)
5.2.3 Global Eliglustat API Production Value Market Share by Type (2019-2030)
5.3 Global Eliglustat API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Eliglustat API Production by Application (2019-2030)
6.1.1 Global Eliglustat API Production by Application (2019-2024)
6.1.2 Global Eliglustat API Production by Application (2025-2030)
6.1.3 Global Eliglustat API Production Market Share by Application (2019-2030)
6.2 Global Eliglustat API Production Value by Application (2019-2030)
6.2.1 Global Eliglustat API Production Value by Application (2019-2024)
6.2.2 Global Eliglustat API Production Value by Application (2025-2030)
6.2.3 Global Eliglustat API Production Value Market Share by Application (2019-2030)
6.3 Global Eliglustat API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Tecoland
7.1.1 Tecoland Eliglustat API Corporation Information
7.1.2 Tecoland Eliglustat API Product Portfolio
7.1.3 Tecoland Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Tecoland Main Business and Markets Served
7.1.5 Tecoland Recent Developments/Updates
7.2 Liverpool Biopharma
7.2.1 Liverpool Biopharma Eliglustat API Corporation Information
7.2.2 Liverpool Biopharma Eliglustat API Product Portfolio
7.2.3 Liverpool Biopharma Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Liverpool Biopharma Main Business and Markets Served
7.2.5 Liverpool Biopharma Recent Developments/Updates
7.3 Clearsynth
7.3.1 Clearsynth Eliglustat API Corporation Information
7.3.2 Clearsynth Eliglustat API Product Portfolio
7.3.3 Clearsynth Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Clearsynth Main Business and Markets Served
7.3.5 Clearsynth Recent Developments/Updates
7.4 Pharmaffiliates
7.4.1 Pharmaffiliates Eliglustat API Corporation Information
7.4.2 Pharmaffiliates Eliglustat API Product Portfolio
7.4.3 Pharmaffiliates Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Pharmaffiliates Main Business and Markets Served
7.4.5 Pharmaffiliates Recent Developments/Updates
7.5 AR Life Sciences
7.5.1 AR Life Sciences Eliglustat API Corporation Information
7.5.2 AR Life Sciences Eliglustat API Product Portfolio
7.5.3 AR Life Sciences Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 AR Life Sciences Main Business and Markets Served
7.5.5 AR Life Sciences Recent Developments/Updates
7.6 Symphony Pharma Life Sciences
7.6.1 Symphony Pharma Life Sciences Eliglustat API Corporation Information
7.6.2 Symphony Pharma Life Sciences Eliglustat API Product Portfolio
7.6.3 Symphony Pharma Life Sciences Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Symphony Pharma Life Sciences Main Business and Markets Served
7.6.5 Symphony Pharma Life Sciences Recent Developments/Updates
7.7 Zhejiang Ausun Pharmaceutical
7.7.1 Zhejiang Ausun Pharmaceutical Eliglustat API Corporation Information
7.7.2 Zhejiang Ausun Pharmaceutical Eliglustat API Product Portfolio
7.7.3 Zhejiang Ausun Pharmaceutical Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Zhejiang Ausun Pharmaceutical Main Business and Markets Served
7.7.5 Zhejiang Ausun Pharmaceutical Recent Developments/Updates
7.8 CoreSyn
7.8.1 CoreSyn Eliglustat API Corporation Information
7.8.2 CoreSyn Eliglustat API Product Portfolio
7.8.3 CoreSyn Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 CoreSyn Main Business and Markets Served
7.7.5 CoreSyn Recent Developments/Updates
7.9 Cangzhou Enke Pharma Tech
7.9.1 Cangzhou Enke Pharma Tech Eliglustat API Corporation Information
7.9.2 Cangzhou Enke Pharma Tech Eliglustat API Product Portfolio
7.9.3 Cangzhou Enke Pharma Tech Eliglustat API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Cangzhou Enke Pharma Tech Main Business and Markets Served
7.9.5 Cangzhou Enke Pharma Tech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Eliglustat API Industry Chain Analysis
8.2 Eliglustat API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Eliglustat API Production Mode & Process
8.4 Eliglustat API Sales and Marketing
8.4.1 Eliglustat API Sales Channels
8.4.2 Eliglustat API Distributors
8.5 Eliglustat API Customers
9 Eliglustat API Market Dynamics
9.1 Eliglustat API Industry Trends
9.2 Eliglustat API Market Drivers
9.3 Eliglustat API Market Challenges
9.4 Eliglustat API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Tecoland
Liverpool Biopharma
Clearsynth
Pharmaffiliates
AR Life Sciences
Symphony Pharma Life Sciences
Zhejiang Ausun Pharmaceutical
CoreSyn
Cangzhou Enke Pharma Tech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂